Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
- DOI
- 10.3389/fphar.2023.1185602
- Published
- 2023-06-28
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2023.1185602,
title = {Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety},
author = {Andrés Ruiz-Sancho and María Núñez-Núñez and Laura Castelo-Corral and Francisco Javier Martínez-Marcos and Nagore Lois-Martínez and Mohd Hafiz Abdul-Aziz and David Vinuesa-García},
year = {2023},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2023.1185602},
url = {https://doi.org/10.3389/fphar.2023.1185602}
}RIS
TY - JOUR TI - Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety AU - Andrés Ruiz-Sancho AU - María Núñez-Núñez AU - Laura Castelo-Corral AU - Francisco Javier Martínez-Marcos AU - Nagore Lois-Martínez AU - Mohd Hafiz Abdul-Aziz AU - David Vinuesa-García PY - 2023 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2023.1185602 UR - https://doi.org/10.3389/fphar.2023.1185602 ER -
APA
Ruiz-Sancho, A., Núñez-Núñez, M., Castelo-Corral, L., Martínez-Marcos, F. J., Lois-Martínez, N., Abdul-Aziz, M. H., & Vinuesa-García, D. (2023). Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1185602
Source records
- crossref · retrieved 2026-09-27T11:50:42.911Z